New York State Teachers Retirement System Sells 136 Shares of Revvity Inc. $RVTY

New York State Teachers Retirement System lessened its holdings in Revvity Inc. (NYSE:RVTY) by 0.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 106,932 shares of the company’s stock after selling 136 shares during the period. New York State Teachers Retirement System owned 0.09% of Revvity worth $10,342,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the business. T. Rowe Price Investment Management Inc. raised its stake in Revvity by 8.5% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company’s stock valued at $2,382,163,000 after acquiring an additional 1,754,403 shares during the period. Vanguard Group Inc. raised its stake in Revvity by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 14,382,849 shares of the company’s stock valued at $1,521,705,000 after acquiring an additional 92,638 shares during the period. Price T Rowe Associates Inc. MD raised its stake in Revvity by 25.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company’s stock valued at $1,011,863,000 after acquiring an additional 1,932,314 shares during the period. EdgePoint Investment Group Inc. raised its stake in Revvity by 32.1% in the 1st quarter. EdgePoint Investment Group Inc. now owns 5,360,847 shares of the company’s stock valued at $567,178,000 after acquiring an additional 1,302,616 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Revvity by 1.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,444,645 shares of the company’s stock valued at $364,443,000 after acquiring an additional 62,307 shares during the period. Institutional investors own 86.65% of the company’s stock.

Revvity Stock Down 0.4%

RVTY stock opened at $93.60 on Friday. The company has a market cap of $10.86 billion, a PE ratio of 39.66, a price-to-earnings-growth ratio of 3.12 and a beta of 0.98. The business has a 50-day simple moving average of $88.59 and a 200 day simple moving average of $92.36. Revvity Inc. has a 52 week low of $81.36 and a 52 week high of $129.50. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.04. The business had revenue of $720.28 million during the quarter, compared to the consensus estimate of $711.26 million. Revvity had a return on equity of 7.66% and a net margin of 10.19%.Revvity’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.22 earnings per share. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. Sell-side analysts anticipate that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Friday, October 17th. Revvity’s payout ratio is 11.86%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on RVTY shares. Raymond James Financial restated an “outperform” rating and issued a $115.00 price target (down previously from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Wall Street Zen downgraded Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 3rd. Barclays dropped their target price on Revvity from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Thursday, October 2nd. Evercore ISI dropped their target price on Revvity from $108.00 to $106.00 and set an “outperform” rating for the company in a report on Tuesday, October 7th. Finally, Bank of America dropped their target price on Revvity from $110.00 to $99.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Nine analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Revvity currently has an average rating of “Moderate Buy” and an average target price of $116.62.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.